about the time and place, afraid, suspicious and speaking incoherently. Physical and neurological exams were otherwise normal. Initial workup included hematological, toxicological, neuroradiologic and electroencephalographic assessments, which were all within normal range. A febrile rash -followed by pruritus, myalgia, arthralgia, periocular pain and posterior cervical adenopathy, which began 14 days before the onset of the behavioral symptoms and remitted after a week -was then reported by his parents.
Transcranial direct current stimulation (tDCS) represents a potential effective treatment for depression and has already shown encouraging results. 1, 2 Given that tDCS requires the subject's presence, the probability of missed sessions is high, especially in depressed subjects. However, there is no consensus about the effects of missed sessions on tDCS efficacy.
A recent study reported that 60% of depressive subjects in a tDCS study missed at least one visit out of ten. 3 It is also known that the intensity and, probably, the frequency of tDCS sessions significantly increase the effectiveness of tDCS. 3 Missing sessions are very frequent, and how to deal with them is an issue of high relevance. Unfortunately, there is a glaring lack of information about missed sessions in tDCS trials for depression, even though this can lead to possible changes in the results and their interpretation. Thus, we can infer that missing sessions is potentially harmful to a complete response by the depressed individual.
We performed a systematic review of the PubMed/ MEDLINE database between 2005 and 2015 regarding methods used to handle missing sessions in trials. Of the eight included trials, only three provided some information about missing sessions ( Table 1 ). The two first trials 4, 5 mentioned the maximum number of sessions that could be missed (no more than two non-consecutive sessions) before excluding the subject and how they handled such cases. Zanã o et al. stated that missing two sessions in the acute treatment phase might not change the final result, although they point out the need for more studies exploring the impact of a higher number of absences on the treatment of depression disorders. The management of this methodological issue is fundamental for scientific development.
Another question is whether there is a relation between the efficacy and timing of a missing session. Do subjects who missed sessions other than at the beginning of the trial have the same results? What about the lasting effects, are they affected by the timing of missing sessions as well? One study made up for the missed tDCS sessions at the end of the protocol. 4 This evidently shows concern with the methodological approach but, again, leads us to question whether the results can be interpreted in the same way for these subjects.
Segrave et al. 11 considered the last observation carried forward as a way of dealing with the missing data due to missed sessions. This is a conservative method that can minimize the good results of tDCS. Moreover, details about how many subjects missed one or more sessions were not provided. The majority of the available articles made no mention of methodological concerns over this issue.
Considering that depressed individuals have difficulty in performing their daily activities, not only having a well-designed plan to address missing sessions but also building an adaptive protocol requires urgent attention. Therefore, clear definitions about how to address them and well-designed guidelines are needed. A new trial specifically designed to assess tDCS efficacy according to the number of missing sessions would certainly help establish a comprehensive framework for informing how many sessions can be missed without having a major impact on the subject. Rivadávio F. Amorim, 1 Monique Gomes da Silva Scalco, 1, 2 Maria Cecília de Freitas-Ferrari, 1, 2 
